Texas A & M University System Health Science Center

Texas A&M University System Health Science Center Finance And Business Services Division, operating as Texas A&M Univ Hlth SCI CTR, is a U.S. state government research and medical education institution that performs biomedical research, clinical training, and specialized health services for federal agencies as a prime recipient and occasional subrecipient. The entity operates as part of the Texas A&M University System, a public higher-education authority headquartered in College Station, Texas, and functions across multiple colleges and clinical locations including Bryan, Dallas (College of Dentistry), Kingsville, and Navasota.

The Health Science Center's recent federal award footprint centers on research grants and educational contracts rather than traditional procurement. Over the past five years (2022–2026), the organization received 279 awards with combined potential value of $62.2 million, though obligated dollars reached $883.7 million—a pattern consistent with multi-year grant commitments and research contracts paid incrementally. Award activity peaked in 2024 (80 awards) and has moderated through 2026 (20 awards to date), likely reflecting grant-award timing cycles rather than demand decline. Eighty-one distinct federal agencies place work with the Health Science Center, but concentration is steep: the top five customer agencies by award count account for only 38% of awards, signaling distributed engagement. By potential value, the National Institute of Allergy and Infectious Diseases dominates with 66 awards totaling $40 million—reflecting the institution's strength in infectious-disease and immunology research.

The organization's concrete capability footprint spans biomedical research (single-investigator and team grants in molecular and cellular biology, neuroscience, immunology, and drug development), clinical training (nursing, dentistry, medicine, and family medicine residencies), specialized medical services (medical-forensic exams, dental care for underserved and HIV-positive populations), and public-health workforce development. Representative recent awards include a $3.86 million CDC contract for assessment of highly pathogenic avian influenza (H5N1) among dairy farm workers (awarded July 2024, due July 2025); a $5.45 million Indian Health Service contract for development and delivery of medical-forensic nurse examiner training (awarded August 2023, ongoing through September 2028); a $1.61 million NIGMS grant for a MINFLUX 3D microscope as a shared research facility (awarded June 2026); and a $1.94 million HHS Nurse Education, Practice, Quality and Retention grant for rural nursing-workforce expansion (awarded September 2025, through September 2029). The institution also holds multiple National Institute of Allergy and Infectious Diseases project grants in fundamental immunology, parasitology, and fungal-infection therapeutics, many running four to five years.

Federal engagement operates primarily through grant and cooperative-agreement vehicles (project grants, cooperative agreements, training grants) managed by NIH, CDC, HRSA, Defense Health Agency, and specialty agencies (NIDCR, NIAAA, NINDS, NEI). The Health Science Center does not compete under GSA Schedules, IDIQs, or BPAs in the traditional federal procurement sense; its awards reflect research and education funding mechanisms. A limited Service Contract Inventory footprint shows $1.7 million in invoiced federal service-contract revenue in FY2024 across two FTEs, at median government-paid rates of $2,591/hr, suggesting that SCI-reportable work is a minor revenue component—the bulk of federal funding flows through research grants and training contracts outside the SCI reporting scope.

The organization operates as a prime recipient in 86% of awards (688 of 798), with the remainder as sub-recipients (110 awards) on collaborative research grants from other academic and research-hospital primes. As a state university health system, the entity competes full-and-open across federal grant programs and does not hold SBA designations; competition for research funding is based on scientific merit through NIH Study Section peer review, CDC grant announcements, and agency-specific solicitations. The recent recompete cliff shows 97 awards with ultimate completion in the next twenty-four months (combined potential value $290 thousand in reported ceilings), though this figure likely underestimates actual recompete exposure—grant continuations and renewals often are processed through non-competitive continuation mechanisms rather than formal recompetition, and the source's potential-value figures reflect conservative estimates for many open-ended research efforts.

The Health Science Center's federal customer base reflects its core mission: research universities and academic medical centers conducting NIH-funded biomedical investigation, HHS workforce-development initiatives, and DoD military-medical research. The institution is positioned as a regional and national research hub for infectious disease, immunology, neuroscience, dental and oral health, nursing education, and medical-forensic services rather than as a federal contractor competing for IT, logistics, or defense-industrial services.